Effect of Vildagliptin and Glimepiride in acute myocardial infarction patients with type 2 diabetes
Not Applicable
Recruiting
- Conditions
- Acute myocardial infarction (AMI) patients with type 2 diabetes
- Registration Number
- JPRN-UMIN000010247
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.AMI for more than 24 hour from onset 2.Contraindicated of Vildagliptin and Glimepiride 3.Renal dysfunction, serum creatinine ≥1.5 mg/dl 4.Informed consent can not be obtained. 5.Patients judged to be unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of acute phase flucose fluctuation and myocardial salvage index in AMI patients with type 2 diabetes
- Secondary Outcome Measures
Name Time Method